From the Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado 80045.
From the Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado 80045
J Biol Chem. 2018 Feb 2;293(5):1551-1567. doi: 10.1074/jbc.M117.813808. Epub 2017 Dec 1.
Both long-term potentiation (LTP) and depression (LTD) of excitatory synapse strength require the Ca/calmodulin (CaM)-dependent protein kinase II (CaMKII) and its autonomous activity generated by Thr-286 autophosphorylation. Additionally, LTP and LTD are correlated with dendritic spine enlargement and shrinkage that are accompanied by the synaptic accumulation or removal, respectively, of the AMPA-receptor regulatory scaffold protein A-kinase anchoring protein (AKAP) 79/150. We show here that the spine shrinkage associated with LTD indeed requires synaptic AKAP79/150 removal, which in turn requires CaMKII activity. In contrast to normal CaMKII substrates, the substrate sites within the AKAP79/150 N-terminal polybasic membrane-cytoskeletal targeting domain were phosphorylated more efficiently by autonomous compared with Ca/CaM-stimulated CaMKII activity. This unusual regulation was mediated by Ca/CaM binding to the substrate sites resulting in protection from phosphorylation in the presence of Ca/CaM, a mechanism that favors phosphorylation by prolonged, weak LTD stimuli brief, strong LTP stimuli. Phosphorylation by CaMKII inhibited AKAP79/150 association with F-actin; it also facilitated AKAP79/150 removal from spines but was not required for it. By contrast, LTD-induced spine removal of AKAP79/150 required its depalmitoylation on two Cys residues within the N-terminal targeting domain. Notably, such LTD-induced depalmitoylation was also blocked by CaMKII inhibition. These results provide a mechanism how CaMKII can indeed mediate not only LTP but also LTD through regulated substrate selection; however, in the case of AKAP79/150, indirect CaMKII effects on palmitoylation are more important than the effects of direct phosphorylation. Additionally, our results provide the first direct evidence for a function of the well-described AKAP79/150 trafficking in regulating LTD-induced spine shrinkage.
长时程增强(LTP)和抑制(LTD)都需要钙/钙调蛋白(CaM)依赖性蛋白激酶 II(CaMKII)及其 Thr-286 自动磷酸化产生的自主活性。此外,LTP 和 LTD 与树突棘的扩大和缩小有关,分别伴随着 AMPA 受体调节支架蛋白 A-激酶锚定蛋白(AKAP)79/150 的突触积累或去除。我们在这里表明,与 LTD 相关的棘缩小确实需要突触 AKAP79/150 的去除,而这反过来又需要 CaMKII 的活性。与正常的 CaMKII 底物不同,AKAP79/150 N 端多碱性膜-细胞骨架靶向结构域内的底物位点通过自主 CaMKII 活性比 Ca/CaM 刺激的 CaMKII 活性更有效地磷酸化。这种不寻常的调节是由 Ca/CaM 与底物位点结合介导的,导致在存在 Ca/CaM 的情况下保护免受磷酸化,这种机制有利于通过延长、弱 LTD 刺激进行磷酸化,而不是通过短暂、强 LTP 刺激。CaMKII 磷酸化抑制 AKAP79/150 与 F-肌动蛋白的结合;它还促进 AKAP79/150 从棘突中去除,但不是必需的。相比之下,LTD 诱导的 AKAP79/150 从棘突中的去除需要其在 N 端靶向结构域内的两个 Cys 残基上的脱棕榈酰化。值得注意的是,这种 LTD 诱导的脱棕榈酰化也被 CaMKII 抑制所阻断。这些结果提供了一种机制,即 CaMKII 如何通过调节的底物选择介导不仅是 LTP,而且是 LTD;然而,在 AKAP79/150 的情况下,CaMKII 对棕榈酰化的间接影响比直接磷酸化的影响更重要。此外,我们的结果提供了第一个直接证据,证明了描述良好的 AKAP79/150 运输在调节 LTD 诱导的棘缩小中的功能。